|Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences|
T Lisman, RJ Porte
Blood 116 (6), 878-885, 2010
|Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity|
T Lisman, TN Bongers, J Adelmeijer, HLA Janssen, MPM de Maat, ...
Hepatology 44 (1), 53-61, 2006
|Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management|
SH Caldwell, M Hoffman, T Lisman, BG Macik, PG Northup, KR Reddy, ...
Hepatology 44 (4), 1039-1046, 2006
|Hemostasis and thrombosis in patients with liver disease: the ups and downs|
T Lisman, SH Caldwell, AK Burroughs, PG Northup, M Senzolo, ...
Journal of hepatology 53 (2), 362-371, 2010
|Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1|
ME Meltzer, T Lisman, PG de Groot, JCM Meijers, S le Cessie, ...
Blood, The Journal of the American Society of Hematology 116 (1), 113-121, 2010
|Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis|
T Lisman, FWG Leebeek, LO Mosnier, BN Bouma, JCM Meijers, ...
Gastroenterology 121 (1), 131-139, 2001
|Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis|
T Lisman, PG De Groot, JCM Meijers, FR Rosendaal
Blood 105 (3), 1102-1105, 2005
|Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1|
RJ Lebbink, T de Ruiter, J Adelmeijer, AB Brenkman, JM van Helvoort, ...
The Journal of experimental medicine 203 (6), 1419-1425, 2006
|Haemostatic abnormalities in patients with liver disease|
T Lisman, FWG Leebeek, PG de Groot
Journal of hepatology 37 (2), 280-287, 2002
|Lupus anticoagulants and the risk of a first episode of deep venous thrombosis|
PG De Groot, B Lutters, R Derksen, T Lisman, JCM Meijers, ...
Journal of Thrombosis and Haemostasis 3 (9), 1993-1997, 2005
|Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury|
ITA Pereboom, MT de Boer, EB Haagsma, HGD Hendriks, T Lisman, ...
Anesthesia & Analgesia 108 (4), 1083-1091, 2009
|Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography|
RT Stravitz, T Lisman, VA Luketic, RK Sterling, P Puri, M Fuchs, A Ibrahim, ...
Journal of hepatology 56 (1), 129-136, 2012
|Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests|
T Lisman, K Bakhtiari, ITA Pereboom, HGD Hendriks, JCM Meijers, ...
Journal of hepatology 52 (3), 355-361, 2010
|Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A|
T Lisman, LO Mosnier, T Lambert, EP Mauser-Bunschoten, JCM Meijers, ...
Blood, The Journal of the American Society of Hematology 99 (1), 175-179, 2002
|Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers|
S Op den Dries, N Karimian, ME Sutton, AC Westerkamp, MWN Nijsten, ...
American Journal of Transplantation 13 (5), 1327-1335, 2013
|Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment|
T Lisman, FWG Leebeek
Digestive surgery 24 (4), 250-258, 2007
|Cell–collagen interactions: the use of peptide Toolkits to investigate collagen–receptor interactions|
RW Farndale, T Lisman, D Bihan, S Hamaia, CS Smerling, N Pugh, ...
Biochemical Society Transactions 36 (2), 241-250, 2008
|The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration|
LO Mosnier, T Lisman, MH Berg, KH Nieuwenhuis, JCM Meijers, ...
Thrombosis and haemostasis 86 (10), 1035-1039, 2001
|A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides|
T Lisman, N Raynal, D Groeneveld, B Maddox, AR Peachey, EG Huizinga, ...
Blood 108 (12), 3753-3756, 2006
|Bleeding in liver surgery: prevention and treatment|
EM Alkozai, T Lisman, RJ Porte
Clinics in liver disease 13 (1), 145-154, 2009